Merck proposal to sell Singulair without a prescription hits resistance
05.05.2014 / Fierce Pharma
Most drugmakers can only watch wistfully as sales of blockbusters fade into the horizon when generics come online. Merck had hoped to keep the memory of asthma drug Singulair's former stature alive by turning it into an over-the-counter (OTC) product. But an FDA panel of experts thinks that is too risky for consumers.